Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO01383) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
MY-5445
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Preclinical/Patented Drug
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=1348"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Inhibited by This Xenobiotics | ||||||
| Phosphodiesterase 5A (PDE5A) | DME Info | Homo sapiens | [1] | |||
| Xenobiotics-DME Activity Data | ||||||
| Xenobiotics-DME Activity Data | Phosphodiesterase 5A (PDE5A) | DME Info | IC50 = 0.5 microM | [1] | ||
| References | ||||||
| 1 | Inhibition of cyclic nucleotide phosphodiesterase by derivatives of 1,3-bis(cyclopropylmethyl)xanthine. J Med Chem. 1994 Feb 18;37(4):476-85. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.